
OptimizeRx
(NASDAQ) OPRX
OptimizeRx Financials at a Glance
Market Cap
$118.39M
Revenue (TTM)
$109.43M
Net Income (TTM)
$5.13M
EPS (TTM)
$0.26
P/E Ratio
24.21
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$6.14
Volume
36,778
Open
$6.31
Price
$6.14
Volume
36,778
Open
$6.31
Previous Close
$6.14
Daily Range
$6.01 - $6.43
52-Week Range
$5.54 - $22.25
Dividend
$0.00
Beta (Volatility)
1.54 (High)
Price
$6.14
Volume
36,778
Open
$6.31
Previous Close
$6.14
Daily Range
$6.01 - $6.43
52-Week Range
$5.54 - $22.25
OPRX News
OPRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout OptimizeRx
Industry
Health Care Technology
Sector
Health CareEmployees
133
CEO
Stephen L. Silvestro
Website
www.optimizerx.comHeadquarters
Waltham, MI 48307, US
OPRX Financials
Key Financial Metrics (TTM)
Gross Margin
63%
Operating Margin
11%
Net Income Margin
5%
Return on Equity
4%
Return on Capital
8%
Return on Assets
3%
Earnings Yield
4.13%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$118.39M
Shares Outstanding
18.76M
Volume
36.78K
Short Interest
0.00%
Avg. Volume
390.71K
Financials (TTM)
Gross Profit
$69.27M
Operating Income
$12.06M
EBITDA
$16.39M
Operating Cash Flow
$18.71M
Capital Expenditure
$58.00K
Free Cash Flow
$18.66M
Cash & ST Invst.
$23.36M
Total Debt
$26.10M
OptimizeRx Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$32.24M
-0.2%
Gross Profit
$19.77M
-10.2%
Gross Margin
61.33%
N/A
Market Cap
$118.39M
N/A
Market Cap/Employee
$924.92K
N/A
Employees
128
N/A
Net Income
$5.02M
+6535.9%
EBITDA
$9.75M
+100.3%
Quarterly Fundamentals
Net Cash
$2.74M
+86.2%
Accounts Receivable
$37.75M
-1.2%
Inventory
$0.00
N/A
Long Term Debt
$21.66M
-30.2%
Short Term Debt
$4.45M
+105.2%
Return on Assets
2.90%
N/A
Return on Invested Capital
7.75%
N/A
Free Cash Flow
$7.08M
+8973.1%
Operating Cash Flow
$7.09M
+3479.8%







